Evelo Biosciences Company
Evelo Biosciences is dedicated to improving the lives of patients globally through the development of monoclonal microbials.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2015
Employees Number:
51-100
Funding Status:
IPO
Total Funding:
281500003
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership